Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Aug 2021 for Guardion Health Sciences, Inc., €9,763.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Robert N. Weingarten: trading record in brief
Filings by Robert N. Weingarten span 2 companies, the busiest being Guardion Health Sciences, Inc. and RespireRx Pharmaceuticals Inc. Over a trading history stretching from 14 April 2014 to 20 August 2021, the count stands at 5 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 23 August 2021 came the latest disclosure, a share grant for €9,763 in Guardion Health Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert N. Weingarten
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
10,000 shares@ US$1.14100.0% of flowCommon Stock, $0.001 par valueSEC:0001493152-21-020894:0
1 of 1 declaration
